Zotarolimus for the treatment of coronary artery disease: pathophysiology, DES design, clinical evaluation and future perspective

Last nail in the coffin of late lumen loss?

(2011) Giuseppe Biondi-Zoccai et al.   EuroIntervention

Lower levels of in-stent late loss are not associated with the risk of stent thrombosis in patients receiving drug-eluting stents

(2011) Fernando Rivero et al.   EuroIntervention

Six-Month Comparison of Coronary Endothelial Dysfunction Associated With Sirolimus-Eluting Stent Versus Paclitaxel-Eluting Stent

(2008) Jin Won Kim et al.   JACC-Cardiovascular Interventions

A Randomized, Controlled, Multicenter Trial to Evaluate the Safety and Efficacy of Zotarolimus- Versus Paclitaxel-Eluting Stents in De Novo Occlusive Lesions in Coronary Arteries

(2008) Bernard Chevalier et al.   JACC-Cardiovascular Interventions

Endothelial Cell Recovery Between Comparator Polymer-Based Drug-Eluting Stents

(2008) Michael Joner et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Differential Effects of Drug-Eluting Stents on Local Endothelium-Dependent Coronary Vasomotion

(2008) Michalis I. Hamilos et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY